CSGALNACT2 Antikörper (AA 61-110)
Kurzübersicht für CSGALNACT2 Antikörper (AA 61-110) (ABIN1534771)
Target
Alle CSGALNACT2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 61-110
-
Verwendungszweck
- CsGalNAcT-2 Antibody
-
Spezifität
- CsGalNAcT-2 Polyclonal Antibody detects endogenous levels of CsGalNAcT-2 protein.
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Reinheit
- > 95 %
-
Immunogen
- The antiserum was produced against synthesized peptide derived from human CSGALNACT2. AA range:61-110
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IHC 1:100 - 1:300. ELISA: 1:40000.. IF 1:50-200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C/1 year
-
Haltbarkeit
- 12 months
-
-
- CSGALNACT2 (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 2 (CSGALNACT2))
-
Andere Bezeichnung
- CSGALNACT2
-
Hintergrund
-
Synonyms: CSGALNACT2, CHGN2, GALNACT2, Chondroitin sulfate N-acetylgalactosaminyltransferase 2, Chondroitin beta-1, 4-N-acetylgalactosaminyltransferase 2, Beta4GalNAcT-2, GalNAcT-2
Background: This gene encodes a member of the chondroitin N-acetylgalactosaminyltransferase family. The encoded protein is involved in elongation during chondroitin sulfate synthesis. Alternative splicing of this gene results in multiple transcript variants. Two related pseudogenes have been identified on chromosome X. [provided by RefSeq, Feb 2016],
Gene Name: CSGALNACT2
Protein Name: Chondroitin sulfate N-acetylgalactosaminyltransferase 2
-
Molekulargewicht
- 62 kDa
-
Gen-ID
- 55454
-
UniProt
- Q8N6G5
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-